Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeji Lim

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Therapeutics|July 14, 2021
Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male VolunteersSeol Ju Moon, Ji-Young Jeon, Yeji Lim, et al.
Toxicology and Applied Pharmacology|December 10, 2025
Duloxetine-induced inhibition of voltage-gated K<sup>+</sup> 3.1 (Kv3.1) channels and underlying electrophysiological mechanismsJin Ryeol An, Junsu Jeong, Hye Ryung Kim, et al.
Journal of Clinical Anesthesia|May 20, 2026
One-minute oscillometric vs. continuous arterial pressure monitoring for hypotension during anesthetic induction in low-risk patients: A randomized noninferiority trialJae-Woo Ju, Hyo Sung Kim, Hyunsook Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2022
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancerKi Young Huh, Yeji Lim, Deok Yong Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Therapeutics|July 14, 2021
Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male VolunteersSeol Ju Moon, Ji-Young Jeon, Yeji Lim, et al.
Toxicology and Applied Pharmacology|December 10, 2025
Duloxetine-induced inhibition of voltage-gated K<sup>+</sup> 3.1 (Kv3.1) channels and underlying electrophysiological mechanismsJin Ryeol An, Junsu Jeong, Hye Ryung Kim, et al.
Journal of Clinical Anesthesia|May 20, 2026
One-minute oscillometric vs. continuous arterial pressure monitoring for hypotension during anesthetic induction in low-risk patients: A randomized noninferiority trialJae-Woo Ju, Hyo Sung Kim, Hyunsook Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2022
Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancerKi Young Huh, Yeji Lim, Deok Yong Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, et al.
Pageof 2